Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023
Por um escritor misterioso
Descrição
VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi
Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences
見時知幾：2023 年Fierce15 藥企預示着哪些投資趨勢- LongPort
Fierce Life Sciences Events on LinkedIn: The Future of Biotech
Fierce Biotech on LinkedIn: The Future of Biotech
Fierce Biotech on LinkedIn: Researchers predict Alzheimer's
見時知幾：2023 年Fierce15 藥企預示着哪些投資趨勢- LongPort
Fierce Life Sciences Events on LinkedIn: There's still time to
Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce
Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences
Georg Winter (@georg_e_winter) / X
Bernd Boidol, Autor bei Proxygen
Introducing Fierce Biotech's 2023 Fierce 15
Fierce Biotech on LinkedIn: BrainStorm's ALS cell therapy
Mark Federici on LinkedIn: Crossbow Therapeutics Launches with $80
